FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)

View source ↗

Summary

The FDA approved Ipca Laboratories Limited's supplemental application for furosemide under an ANDA, updating the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis with Ascites
• Edema
• Heart Failure
• Hypertension
• Nephrotic Syndrome
• Pulmonary Edema

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)